Abiopharma

Clinical trial NCT07035431: start date: 2026-05-01 → 2026-07-01.

Clinical trial NCT06497556: primary completion date: 2027-09-30 → 2026-05-19.

Clinical trial NCT05156983 updates: 1. completion date: 2028-04-12 → 2028-08-30 2. primary completion date: 2028-04-12 → 2028-08-30 3. enrollment: 328 → 440 participants

Clinical trial NCT01160783 updates: 1. completion date: 2028-02-01 → 2030-02-01 2. primary completion date: 2027-12-01 → 2028-12-01

Clinical trial NCT06714552 updates: 1. status: COMPLETED → ACTIVE_NOT_RECRUITING 2. completion date: 2026-04-13 → 2026-07-31

Clinical trial NCT05114538: completion date: 2026-05-31 → 2027-05-31.

Clinical trial NCT02932150: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT05221840: primary completion date: 2026-06-30 → 2026-09-30.

Clinical trial NCT07563894 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07221253 updates: 1. completion date: 2029-07-04 → 2029-07-31 2. primary completion date: 2029-07-04 → 2029-07-31